Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Income from Continuing Operations: 2021-2024

Historic Income from Continuing Operations for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -$17.8 million.

  • Biofrontera's Income from Continuing Operations fell 17.29% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 36.89%. This contributed to the annual value of -$17.8 million for FY2024, which is 11.78% up from last year.
  • As of FY2024, Biofrontera's Income from Continuing Operations stood at -$17.8 million, which was up 11.78% from -$20.1 million recorded in FY2023.
  • Biofrontera's Income from Continuing Operations' 5-year high stood at -$640,000 during FY2022, with a 5-year trough of -$37.7 million in FY2021.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$17.8 million (2024), whereas its average is -$12.8 million.
  • Per our database at Business Quant, Biofrontera's Income from Continuing Operations skyrocketed by 98.30% in 2022 and then crashed by 3,045.47% in 2023.
  • Biofrontera's Income from Continuing Operations (Yearly) stood at -$37.7 million in 2021, then soared by 98.30% to -$640,000 in 2022, then slumped by 3,045.47% to -$20.1 million in 2023, then rose by 11.78% to -$17.8 million in 2024.